<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170611034454N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-12-03</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>Comparison the effect of multi-sensory stimulation intervention and aromatherapy with lavender essence on anxiety, depression and well-being in the elderly undergoing hemodialysis</public_title>
      <acronym>مقایسه ی تاثیر تحریکات چند حسی و رایحه درمانی با اسطوخودوس بر اضطراب، افسردگی و احساس خوب بودن سالمندان همودیالیزی</acronym>
      <scientific_title>Comparison the effect of multi-sensory stimulation intervention and aromatherapy inhalation with lavender essential oil on anxiety, depression and well-being in the elderly undergoing hemodialysis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-12-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/43727</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Randomization description: The method of random allocation of the samples to the two groups will be blocking. The blocking is done with random allocation software and 11 quadruple blocks are generated with the software then samples with inclusion criteria are assigned to each of the multi-sensory stimulation or aromatherapy groups accordingly. To hide the random allocation, 44 non-transparent envelopes (for the sake of clarity of envelope content) were prepared, and each random sequence generated was recorded on a card and the cards were inserted in the envelope respectively. In order to maintain a random sequence, the outer surface of the envelopes is numbered in the same order. Finally, the envelope door is glued and placed in a box, respectively. At the time the participants begin to register, based on the order of entry of the eligible participants into the study, one of the envelopes, respectively, opened and the assigned group of the participant is revealed.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Anxiety. Condition 2: Depression. Condition 3: Hemodialysis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 2: Multi-sensory stimulation intervention will include three types of stimulation in the form of auditory, visual and olfactory stimulation that will be performed in the hemodialysis ward of Sari Dialysis Center during hemodialysis on elderly patients undergoing hemodialysis. Auditory stimulation will be performed using relaxing and unassuming music playing with the sound of nature from Dan Gibson's collection of relaxing music songs with the sound of nature (birds singing, water sounds). Visual stimulation will be done using nature images (video slide shows and audio playback via a laptop (15-inch Lenovo E-ideapad 330 and headphones). Auditory and visual stimulation will be performed simultaneously for 10 minutes, then the elderly will rest for 5 minutes, and for 10 minutes the olfactory stimulation (aromatherapy) will be performed so that patients in the multi-sensory stimulation group will inhale the lavender essential oil. The patients of the multi-sensory stimulation groups will inhalated lavender essential oil that is diluted with almond oil in a ratio of 1:20 (5% lavender essential oil), both produced by Barij Essence Pharmaceuticals and are ISO 9001 certified and ISO/IEC 17025 certified. Patients receive lavender inhalation three days a week, alternately on Saturdays, Mondays, and Wednesdays for 4 weeks. So that a cotton ball impregnated with 3 drops of lavender essential oil at a concentration of 5% (diluted with sweet almond oil at a ratio of 1:20) adheres to the patient's collar and is asked to sit for 10 minutes to breathe normally. People are also asked not to use any perfume or cologne or other fragrance before or during the intervention. Finally, in the multi-sensory stimulation group, the three-week multi-sensory stimulation intervention will be performed on a daily basis in the even days (Saturday, Monday, Wednesday) for four weeks. Each session will last a total of 25 minutes. Intervention 2: Intervention group 2: Patients in the aromatherapy group will inhale the almond oil diluted with sweet almond oil for a period of 10 minutes in a ratio of 1:20 (5% lavender essential oil) that are produced by Barij Essence Pharmaceutical Company, it has ISO 9001 quality certified and ISO/ IEC 17025 standard. Patients receive lavender inhalation three days a week, alternately on Saturdays, Mondays, and Wednesdays for 4 weeks in the same way as aromatherapy in the multi-sensory stimulation group and will not receive visual and auditory stimuli.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ehteram Sadat Ilali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nasibe Nursing and Midwifery School, Vesal Street</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816715793</zip>
        <telephone>+98 11 3329 4601</telephone>
        <email>paradis2082000@yahoo.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ehteram Sadat Ilali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nasibe Nursing and Midwifery School, Vesal street</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816715793</zip>
        <telephone>+98 11 3336 7374</telephone>
        <email>paradis2082000@yahoo.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Chronological age 60 and older
Alertness and ability to communicate (ability to answer questions)
Normal cognitive status based on abbreviated mental test (AMT) (score 7 and above)
Mild to moderate anxiety (score 16-10)
Mild to moderate depression (score 5-11)
Having a hemodialysis history at least 6 months and at least 3 hemodialysis sessions per week
Having sensory health of hearing, sight and smell
No allergies to lavender odor
No alcohol use and no opioid or
No experience of any event that may cause increasing mental pressure on a person (death of a spouse or other family member, divorce, serious illness and other adverse events) 6 months ago
No participation in the anxiety and depression classes concurrently or not being consulted with a psychologist or psychiatrist
No psychotropic drugs (sedatives/ hypnotics/ antidepressants/ anti-anxiety) use</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Incidence of allergy to perfume during intervention
Candidate for Kidney Transplant
Having other Neuropsychiatric Disorders
Absence of more than three sessions at the time of intervention
Lack of interest to music
withdrawal or unwillingness to Continue to study
die</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F06.4</hc_code>
      <hc_code>F32.9</hc_code>
      <hc_code>Z49.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Organic anxiety disorder</hc_keyword>
      <hc_keyword>Depressive episode, unspecified</hc_keyword>
      <hc_keyword>Dialysis (renal) NOS</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 2: Multi-sensory stimulation intervention will include three types of stimulation in the form of auditory, visual and olfactory stimulation that will be performed in the hemodialysis ward of Sari Dialysis Center during hemodialysis on elderly patients undergoing hemodialysis. Auditory stimulation will be performed using relaxing and unassuming music playing with the sound of nature from Dan Gibson's collection of relaxing music songs with the sound of nature (birds singing, water sounds). Visual stimulation will be done using nature images (video slide shows and audio playback via a laptop (15-inch Lenovo E-ideapad 330 and headphones). Auditory and visual stimulation will be performed simultaneously for 10 minutes, then the elderly will rest for 5 minutes, and for 10 minutes the olfactory stimulation (aromatherapy) will be performed so that patients in the multi-sensory stimulation group will inhale the lavender essential oil. The patients of the multi-sensory stimulation groups will inhalated lavender essential oil that is diluted with almond oil in a ratio of 1:20 (5% lavender essential oil), both produced by Barij Essence Pharmaceuticals and are ISO 9001 certified and ISO/IEC 17025 certified. Patients receive lavender inhalation three days a week, alternately on Saturdays, Mondays, and Wednesdays for 4 weeks. So that a cotton ball impregnated with 3 drops of lavender essential oil at a concentration of 5% (diluted with sweet almond oil at a ratio of 1:20) adheres to the patient's collar and is asked to sit for 10 minutes to breathe normally. People are also asked not to use any perfume or cologne or other fragrance before or during the intervention. Finally, in the multi-sensory stimulation group, the three-week multi-sensory stimulation intervention will be performed on a daily basis in the even days (Saturday, Monday, Wednesday) for four weeks. Each session will last a total of 25 minutes.</i_keyword>
      <i_keyword>Intervention group 2: Patients in the aromatherapy group will inhale the almond oil diluted with sweet almond oil for a period of 10 minutes in a ratio of 1:20 (5% lavender essential oil) that are produced by Barij Essence Pharmaceutical Company, it has ISO 9001 quality certified and ISO/ IEC 17025 standard. Patients receive lavender inhalation three days a week, alternately on Saturdays, Mondays, and Wednesdays for 4 weeks in the same way as aromatherapy in the multi-sensory stimulation group and will not receive visual and auditory stimuli.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety. Timepoint: Before the intervention, at the end of the second and fourth weeks after the intervention and one week after the intervention. Method of measurement: Geriatric Anxiety Inventory (GAI).</prim_outcome>
      <prim_outcome>Depression. Timepoint: Before the intervention, at the end of the second and fourth weeks after the intervention and one week after the intervention. Method of measurement: Geriatric Depression Scale (GDS).</prim_outcome>
      <prim_outcome>Well-being. Timepoint: Before the intervention, at the end of the second and fourth weeks after the intervention and one week after the intervention. Method of measurement: Well-being Index (WHO-5-P).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-11-17</approval_date>
        <contact_name>Ethics committee of Mazandaran University of Medical Sciences</contact_name>
        <contact_address>Mazandaran University of Medical Siences (Vice chanchellor for research), Moallem Square Sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
